Eric Laub | Vice President-Investor Relations |
Richard Murray | Chief Executive Officer & President |
Beth Trehu | Chief Medical Officer |
Dmitri Wiederschain | Chief Scientific Officer |
Kim Drapkin | Chief Financial Officer |
Edward Tenthoff | Piper Sandler |
Boris Peaker | Cowen |
Steven Seedhouse | Raymond James |
David Dai | SMBC |
Swayampakula Ramakanth | HCW |
Nick Abbott | Wells Fargo |
Good morning, ladies and gentlemen, and welcome to the Jounce Therapeutics Second Quarter -- 2022 Earnings Conference Call. At this time, all participants are in a listen-only mode. Later, we will conduction a question-and-answer session and instructions will follow at that time.
As a reminder, this conference is being recorded at the company's request. I will now turn the call over to your host, Eric Laub with Jounce Therapeutics.